COVID-19 Resources

As the COVID-19 pandemic continues to unfold, UVA LVG is committed to helping our UVA faculty, staff, and students innovators, our licensees, and our startup companies navigate the challenges faced during these uncertain times.

We have compiled the following resources to support UVA researchers and entrepreneurs during the COVID-19 pandemic. Sources include the UVA Office of the Vice President for Research, the U.S. Department of Labor, the U.S. Small Business AdministrationThe City of Charlottesville Office of Economic DevelopmentCvilleBioHubVirginia.GovVirginia SBDC, and many others. Thank you for making this information available.

In accordance with UVA's operations policy, our team is working remotely and available to assist via phone, email and zoom. We will continue to update this list, and welcome feedback and additional resources. Please email us at lvg@virginia.edu.

Last updated: November 20, 2020 

COVID-19 Tech Licensing Guidelines

The UVA Licensing & Ventures Group had adopted the following COVID-19 Licensing Guidelines put forth by leading technology transfer industry organization, AUTM.

The guidelines are as follows:

  1. Technology transfer accelerates innovations that impact society and promotes the broad distribution of public health solutions. We encourage intellectual property (IP) owners to adopt a COVID-19 licensing strategy that facilitates rapid pandemic response by licensees and to make the execution of associated transactions a top priority.
  2. For most technologies, where legally possible, this strategy is best accomplished by adopting time-limited, non-exclusive royalty-free licenses, in exchange for the licensees’ commitment to rapidly make and broadly distribute products and services to prevent, diagnose, treat and contain COVID-19 and protect healthcare workers during the pandemic (as defined by the World Health Organization).
  3. Licenses may subsequently convert to a more typical commercial license as appropriate. Licenses must also preserve the licensor’s freedom to publish and use the intellectual property for teaching and research.

To see the full list of university signatories, visit the AUTM website.

University of Virginia

November 2020: Phase II. (We are in phase II) 

On-grounds density levels can increase as disease spread in the labs is deemed under control and effectively monitored, and/or management and treatments options are successfully advanced to acceptable levels set forth by the Commonwealth.

UVA Research Guidelines for Gradual Reopening

(Updated on November 19, 2020)

To reduce the risks of researchers potentially being exposed to SARS-CoV-2 in the laboratory and research spaces or exposing others to it as we ramp up of research, we aim to gradually increase the density of our research personnel through ramping up in phases with a set of safety guidelines.

Current knowledge and the advice from epidemiologists and health experts point to three important elements that will help keep you and others safe. They are: (i) wearing a face covering; (ii) regularly washing your hands and the environment around you clean; and (iii) keeping your distance from other people. We have developed our safety guidelines that expand on these elements and contextualize them for our research environments. As new knowledge emerges, we will provide additional guidance to further reduce the risks.

Our general principle is that only research activities requiring on-Grounds presence would be conducted on-Grounds. All other research-related work would continue to be performed by telework until restrictions are lifted. Separate school, department and building specific plans should supplement these guidelines.

For research that needs to be on Grounds, the plan is to ramp up in phases with emphasis on safety. The goal of this document is to provide a central framework for resuming activities while allowing for coordinated school specific implementation strategies.

The success of the ramp up depends on each researcher placing the safety of themselves and the people around them first, while conducting their research. In order to reduce our risks as much as possible, this must be a partnership between the researchers and the administration.

All researchers are expected to fully comply with the policies, protocols and guidelines outlined in this document. Failure to do so may result in loss of research space access privileges.

Schools are developing a process for the approval of ramp up requests and enforcement of safety guidelines described in this document. The VPR office is working with the schools to provide the necessary support for business process infrastructure, and working with the COO’s office to coordinate the acquisition of supplies necessary including face coverings and sanitizing supplies.

We thank you in advance for your commitment. The following are the key safety expectations for ramping up research.

COVID-19 Translational Research Funds

Ivy Foundation Backs 14 COVID Translational Research Projects

By: Meredith Cole

UVA has selected 14 promising biomedical research projects to receive funding from the Ivy Foundation COVID-19 Translational Research Fund.

The projects include development of biosensors, artificial intelligence for testing, vaccine development, novel treatment options and better data analytics to predict the spread of the virus.

“We felt it was important to use our resources to help our community, and to leverage the breadth of the University of Virginia’s research to make an impact with COVID-19,” Dr. Bobby Battle, who chairs the Ivy Foundation, said. “We’re really impressed with the range and quality of the projects funded.

“We would like to thank the review committee, consisting of diverse experts on broad range of topics, including one of the world’s leading experts on SARS virus, for contributing their time and expertise to direct us toward projects that may change the COVID-19 landscape.”

The Charlottesville-based Ivy Foundation committed $2 million in May to help accelerate biomedical research on COVID-19 at UVA and to support research that addresses the diagnosis, treatment options, vaccine development and health care worker protection needs for COVID-19.

The Manning Fund for COVID-19 Research

Eight Research Projects Receive Funding From Manning Fund for COVID-19 Research

By: Meredith Cole

recent gift of $1 million from the Manning family, strong supporters of the University of Virginia, established The Manning Fund for COVID-19 Research, designed to support the University’s practically oriented research on COVID-19-related topics that can be acted upon quickly and have commercial potential.

More than 50 proposals were received from UVA faculty for projects related to developing COVID-19-related solutions.

A recent gift from entrepreneur Paul Manning established a fund designed to support UVA research on COVID-19-related topics that can be acted upon quickly and have commercial potential. (Contributed photo)

The offices of the Provost and the Vice President for Research, which co-manage the fund, have funded eight proposals that support improved antibody testing, vaccine development and improving patient outcomes.

“These researchers showed they had both great ideas for conquering COVID-19, and a solid plan for how to accomplish their goals,” said Melur “Ram” Ramasubramanian, vice president for research. “We couldn’t be more pleased with the projects proposed and their potential impact.”

“Many of our researchers have set current and pressing projects aside to redirect their energies to COVID-19,” said Liz Magill, the University’s provost. “We’re grateful that the Manning Fund has enabled this critical research that takes advantage of the cross-disciplinary networks UVA has nurtured over the past few years.”

“I want to thank the entire research team and administration for their acute sense of urgency and entrepreneurship to come up with these helpful solutions to the COVID crisis. They set short term goals and achieved them,” said local businessman and investor Paul Manning. “I am very grateful.”

Funding for Research Related to COVID19

Resources for Researchers Related to COVID-19

Virginia Resources & Funding

SBA Coronavirus Pandemic Disaster Loan Details

Small Business Administration (SBA) Economic Injury Disaster Loans

Virginia has officially received an Economic Injury Disaster Loan declaration from the U.S. Small Business Administration (SBA). 

Small businesses and non-profits located throughout the state can now apply for a loan of up to $2 million from the SBA to pay fixed debts, payroll, accounts payable, and other expenses. 

To submit a loan application for the SBA Economic Injury Disaster Loan program, please visit: https://disasterloan.sba.gov/ela/.

Payment Extension and Waiver of Late Payment Penalties

Businesses impacted by coronavirus can request an extension of the due date for filing and payment of their February 2020 sales tax return due March 20, 2020, for 30 days. When granted, businesses will be able to file and pay no later than April 20, 2020 with a waiver of any penalties.

The Virginia Department of Taxation is extending the due date of payment of Virginia individuals and corporate income taxes. While filing deadlines remain the same, the due date for individual and corporate income tax will now be June 1, 2020.

Please note that interest will still accrue, so taxpayers who are able to pay by the original deadlines should do so.

More information: Virginia Tax Online Services for Businesses

The Virginia Employment Commission no longer requires the one-week waiting period so workers are able to receive benefits right away. For more information visit HERE.

Virginia 30 Day Fund – Forgivable loans for Virginia small businesses

Charlottesville Resources & Funding

10/19/20 - City of Charlottesville Small Business Relief Grant Program

City of Charlottesville Economic Development Authority:

City Delivers $750,000 in Relief to Small Businesses

  • The City of Charlottesville Office of Economic Development (OED) is pleased to announce that 128 small businesses have received funds from the Small Business Relief Grant (SBRG) program. The full list can be found at the Small Business Relief Grant link.

Rebuild VA

  • State launches Rebuild VA Grant Fund to assist small businesses and nonprofits impacted by COVID-19.  The application will be available on August 10th, 2020.  See Rebuild VA (PDF) for more information and to review the eligibility criteria.

Local Business Stimulus Program

As a business owner, you have lived this change over the past few months. Your customers are looking to do business with you in new ways, asking for new services and looking for new ways to connect every day. That’s why we stand ready to build on our commitment to help your business succeed with our Local Business Stimulus Program. With our large local audiences and world class digital services like text marketing, website design and managed search campaigns, we can put together the right combination to help your business not only tackle change, but thrive in it.

U.S. Small Business Administration (SBA) Economic Injury Disaster Loans (EIDL)offering low-interest federal disaster loans for working capital to small businesses suffering substantial economic injury as a result of the Coronavirus (COVID-19). 

U.S. Senate Committee on Small Business & EntrepreneurshipCoronavirus Aid, Relief, and Economic Security (CARES) Act intends to assist business owners with whatever needs they have right now.

The City of Charlottesville Office of Economic Development (OED) and the Charlottesville Economic Development Authority (CEDA) are offering new funding programs for City businesses. Current opportunities include:

  • Business Equity Fund (BEF) Resiliency Loan for socially disadvantaged City businesses. Pre-screen application now available HERE.
  • Growing Opportunities (GO) Hire Grant for wage subsidies and training. Applications open April 13. Contact ecodev@charlottesville.org for more information
  • Building Resilience Among Charlottesville Entrepreneurs (BRACE) Grant – Application period now closed.